JPH0587064B2 - - Google Patents

Info

Publication number
JPH0587064B2
JPH0587064B2 JP1168247A JP16824789A JPH0587064B2 JP H0587064 B2 JPH0587064 B2 JP H0587064B2 JP 1168247 A JP1168247 A JP 1168247A JP 16824789 A JP16824789 A JP 16824789A JP H0587064 B2 JPH0587064 B2 JP H0587064B2
Authority
JP
Japan
Prior art keywords
formula
dystrontium
salt
carboxymethyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1168247A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0248567A (ja
Inventor
Uieruzubitsuki Misheru
Bone Jatsukuriinu
Tsuodero Yani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Servier de Medecine Translationnelle SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of JPH0248567A publication Critical patent/JPH0248567A/ja
Publication of JPH0587064B2 publication Critical patent/JPH0587064B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
JP1168247A 1988-06-29 1989-06-29 新規ストロンチウム塩 Granted JPH0248567A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8808729A FR2633619B1 (fr) 1988-06-29 1988-06-29 Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR8808729 1988-06-29

Publications (2)

Publication Number Publication Date
JPH0248567A JPH0248567A (ja) 1990-02-19
JPH0587064B2 true JPH0587064B2 (enExample) 1993-12-15

Family

ID=9367847

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1168247A Granted JPH0248567A (ja) 1988-06-29 1989-06-29 新規ストロンチウム塩

Country Status (16)

Country Link
US (1) US4939164A (enExample)
EP (1) EP0349432B1 (enExample)
JP (1) JPH0248567A (enExample)
AT (1) ATE81118T1 (enExample)
AU (1) AU613297B2 (enExample)
CA (1) CA1312333C (enExample)
DE (1) DE68903059T2 (enExample)
DK (1) DK325289A (enExample)
ES (1) ES2044170T3 (enExample)
FR (1) FR2633619B1 (enExample)
GR (1) GR3006674T3 (enExample)
IE (1) IE64112B1 (enExample)
NZ (1) NZ229760A (enExample)
OA (1) OA09121A (enExample)
PT (1) PT91006B (enExample)
ZA (1) ZA894945B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
PT1534305E (pt) * 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
PT1622630E (pt) * 2003-05-07 2012-10-11 Osteologix As Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
US20080167513A1 (en) * 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
DK1768748T4 (da) 2004-06-25 2019-06-11 Mokwalo Spf S A Sammensætninger omfattende strontium og vitamin D og anvendelser deraf
US7875627B2 (en) * 2004-12-07 2011-01-25 Abbott Laboratories Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
WO2016058753A1 (en) 2014-10-14 2016-04-21 Unilever N.V. Device for spraying an enclosure triggered by inclination of a rotatable lid
US10183308B2 (en) 2014-10-14 2019-01-22 Conopco, Inc. Spraying device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2954384A (en) * 1960-09-27 Method for preparing kainic acid and its
DE3127275A1 (de) * 1980-12-11 1983-01-27 Leskovar, Peter, Dr.-Ing., 8000 München "harnsteinaufloesende mittel"

Also Published As

Publication number Publication date
IE64112B1 (en) 1995-07-12
ATE81118T1 (de) 1992-10-15
FR2633619B1 (fr) 1991-02-08
CA1312333C (fr) 1993-01-05
JPH0248567A (ja) 1990-02-19
PT91006A (pt) 1989-12-29
GR3006674T3 (enExample) 1993-06-30
IE892094L (en) 1989-12-29
AU3709289A (en) 1990-01-04
PT91006B (pt) 1994-11-30
NZ229760A (en) 1991-06-25
DK325289D0 (da) 1989-06-29
ES2044170T3 (es) 1994-01-01
DE68903059T2 (de) 1993-04-29
ZA894945B (en) 1990-03-28
EP0349432A1 (fr) 1990-01-03
FR2633619A1 (fr) 1990-01-05
DK325289A (da) 1989-12-30
US4939164A (en) 1990-07-03
OA09121A (fr) 1991-10-31
DE68903059D1 (de) 1992-11-05
AU613297B2 (en) 1991-07-25
EP0349432B1 (fr) 1992-09-30

Similar Documents

Publication Publication Date Title
ES2062450T4 (es) Sales metálicas bivalentes del ácido n,n-di(carboximetil)-2-amino-3-ciano-4-carboximetil-5-carboxi-tiofeno y su procedimiento de preparacion.
HK1042483B (zh) 四氫噻唑的製造方法
JPH0248567A (ja) 新規ストロンチウム塩
JPH0150698B2 (enExample)
FI63568B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara i 7-staellning substituerade 8-aminometylisoflavonderivat
RU2145602C1 (ru) Способы получения ламотриджина, промежуточные соединения и способ получения фармацевтической композиции
US4298609A (en) 4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol and salts, their preparation and use as blood pressure lowering agents
JPS5827263B2 (ja) Ｎ−アシル−αおよびβ−アスパルチルグルタミン酸塩の製造方法
RU2004539C1 (ru) Полистиролсульфонат 4-[3-[этил[-3-(пропилсульфинил)-пропил) амино)-2-оксипропокси]бензонитрила в виде смеси стереоизомеров или чистого стереоизомера, обладающий антиаритмическим действием
WO2009078746A1 (en) Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof
JPS63264549A (ja) 乳酸カルシウム‐グリセロール付加物およびその製法
JPS5910563A (ja) α−（Ｎ−ピロリル）−フエニル酢酸誘導体およびその製造方法
JPS6014026B2 (ja) パンテテイン−ｓ−スルホン酸及びその塩の製造法
CN1326845C (zh) 双苯氟嗪的制备方法
JPS6026386B2 (ja) 新規イソインド−ル化合物
CN102791700A (zh) 用于制备雷尼酸锶多晶型的方法
DK156395B (da) Analogifremgangsmaade til fremstilling af et (3-pyrrolidinopropyl)-ketonderivat
KR101007927B1 (ko) 시부트라민-ｌ-카르니틴 다이술폰산염, 이의 제조방법 및 이를 포함하는 약제학적 조성물
JP2002542230A (ja) ５−クロロ−２−メトキシ−ｎ−（２−（４−メトキシ−３−メチルアミノチオカルボニルアミノスルホニルフェニル）エチル）ベンズアミドナトリウム塩の結晶形
JPS6147496A (ja) １―デソキシ―（５―ヒドロキシトリプトアミノ）―ｄ―フラクトースおよび１―メチルヒダントイン―２―イミドの硫酸塩、その製造法および医薬
NO159587B (no) Fremgangsm te for fremstilling av 2-(parasubstituersy)-2-alkylpropionsyrederivater.
CN107540672A (zh) 一种治疗肝硬化的药物及其合成方法
JPS62281852A (ja) パンテチンの製造法
JPS62111969A (ja) ホモカルノシン亜鉛塩
SK280602B6 (sk) Viacjadrové komplexné zlúčeniny horčíka s aminodik